I will do my best.
Let me first of all draw your attention to subsection 37(1) of the Food and Drugs Act, which is not changed by all of this. It is already the case in Canada that any drug that is made in Canada for export is not subject to Health Canada review; it is only in the case of a drug that is produced under CAMR for export that the requirement was made that Health Canada must review it. There was already, if you will, a demonstrated lack of concern on the part of the Canadian government for drugs being exported. However--